MannKind Corp
MNKD
#6530
Rank
S$0.91 B
Marketcap
S$2.96
Share price
0.88%
Change (1 day)
-56.44%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): S$41 Million

According to MannKind Corp's latest financial reports the company's current earnings are S$0.31 Billion. In 2024 the company made an earning of S$39.22 Million, an increase over its 2023 earnings that were of -S$13.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$41 M4.53%
2024 S$39.22 M-394.09%
2023 -S$13.34 Million-88.13%
2022 -S$0.12 Billion8%
2021 -S$0.11 Billion40.84%
2020 -S$73.86 Million10.7%
2019 -S$66.72 Million-40.16%
2018 -S$0.12 Billion-26.04%
2017 -S$0.16 Billion-193.33%
2016 S$0.16 B-134.11%
2015 -S$0.48 Billion85.72%
2014 -S$0.26 Billion3.6%
2013 -S$0.25 Billion12.79%
2012 -S$0.22 Billion5.58%
2011 -S$0.21 Billion-5.72%
2010 -S$0.22 Billion-22.51%
2009 -S$0.29 Billion-27.37%
2008 -S$0.39 Billion3.36%
2007 -S$0.38 Billion27.18%
2006 -S$0.3 Billion101.63%
2005 -S$0.15 Billion50.46%
2004 -S$97.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.10 B 33,009.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$26.94 B 67,994.73%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
S$33.07 B 83,488.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$28.82 B 72,742.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
S$0.60 B 1,416.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-S$0.2 Billion-605.11%๐Ÿ‡บ๐Ÿ‡ธ USA